CA
Therapeutic Areas
Perrigo Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ibuprofen Tablets 200 mg | Pain Relief / Fever Reduction | Approved |
| Acetaminophen (Extra Strength) | Pain Relief / Fever Reduction | Approved |
| Advantage® Non-GMO Infant Formula | Infant Nutrition | Approved |
| Minoxidil Topical Solution USP 5% | Hair Regrowth Treatment | Approved |
| Nicotine Polacrilex Lozenge 4 mg | Smoking Cessation | Approved |
| Loratadine Tablets 10 mg | Allergy Relief | Approved |
| Famotidine Tablets 20 mg | Heartburn Relief | Approved |
| Omeprazole Delayed Release Tablets 20 mg | Frequent Heartburn | Approved |
Leadership Team at Perrigo
PL
Patrick Lockwood-Taylor
President & Chief Executive Officer
DB
David Ball
Executive Vice President, Chief Brand and Digital Officer
EB
Eduardo Bezerra
Executive Vice President and Chief Financial Officer
RK
Roberto Khoury
Executive Vice President & Chief Commercial Officer
AL
Abbie Lennox
Executive Vice President & Chief Scientific Officer
RW
Rob Willis
Executive Vice President & Chief Human Resources Officer
MW
Matt Winterman
Executive Vice President, Product Supply, Operations Strategy & Transformation Officer